|
| dbGaP Submitter Subject ID (ID2) | Coriell Sample ID | Consent | Control | Gender | Race | Age | Baseline Max AMD Severity | Final Max AMD Severity |
| AR2_0008 | ED150003 | General Research Use | No | Male | White | 59 | 3 - AREDS AMD Severity Scale Step 3 | 6 - AREDS AMD Severity Scale Step 6 |
| AR2_0837 | ED149284 | General Research Use | No | Female | White | 58 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0993 | ED148670 | General Research Use | No | Female | White | 55 | 6 - AREDS AMD Severity Scale Step 6 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_1085 | ED148614 | General Research Use | No | Female | White | 58 | 7 - AREDS AMD Severity Scale Step 6 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1465 | ED149454 | General Research Use | No | Male | White | 57 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2017 | ED149665 | General Research Use | No | Female | White | 58 | 3 - AREDS AMD Severity Scale Step 3 | 4 - AREDS AMD Severity Scale Step 4 |
| AR2_2452 | ED149529 | General Research Use | No | Female | White | 56 | 8 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2991 | ED148417 | General Research Use | No | Male | Native Hawaiian or other Pacific | 59 | 4 - AREDS AMD Severity Scale Step 4 | 5 - AREDS AMD Severity Scale Step 5 |
| AR2_4188 | ED148150 | General Research Use | No | Female | White | 59 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0660 | ED148912 | General Research Use | No | Female | White | 57 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0903 | ED149944 | General Research Use | No | Female | White | 59 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1236 | ED149259 | General Research Use | No | Female | White | 57 | 7 - AREDS AMD Severity Scale Step 7 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1841 | ED149640 | General Research Use | No | Female | White | 58 | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue | 11b - Neovascular AMD with end-stage disease (e.g., definite disciform scar, or photocoagulation scar), or two or more of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_2861 | ED149548 | General Research Use | No | Male | Other | 57 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0066 | ED148141 | General Research Use | No | Male | White | 58 | 7 - AREDS AMD Severity Scale Step 7 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_0136 | ED149197 | General Research Use | No | Female | White | 57 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_0142 | ED148483 | General Research Use | No | Male | White | 58 | 8 - AREDS AMD Severity Scale Step 6 | 11a - Neovascular AMD with definite presence of one of the following five characteristics of neovascular AMD: SSR detachment, PED, subretinal/sub-RPE hemorrhage, hard exudate, or fibrous tissue |
| AR2_1020 | ED149351 | General Research Use | No | Female | White | 58 | 7 - AREDS AMD Severity Scale Step 7 | 8 - AREDS AMD Severity Scale Step 8 |
| AR2_3261 | ED149008 | General Research Use | No | Female | White | 56 | 7 - AREDS AMD Severity Scale Step 7 | 7 - AREDS AMD Severity Scale Step 7 |
| AR2_3354 | ED149003 | General Research Use | No | Male | White | 58 | 8 - AREDS AMD Severity Scale Step 8 | 9 - AREDS AMD Severity Scale Step 9 |